Structural and compositional determinants of cortistatin activity

Journal of Neuroscience Research

Volumn 56, Issue 6, 1999, Pages 611-619

  Criado, José R ^a   Li, Haitao ^b   Jiang, Xiaohui ^b   Spina, Mariarosa ^a   Huitrón Reséndiz, Salvador ^a   Liapakis, George ^c,e   Calbet, Marta ^a   Sichler, Sandra ^d   Henriksen, Steven J ^a   Koob, George ^a   Hoyer, Daniel ^d   Sutcliffe, J Gregor ^a   Goodman, Murray ^b   De Lecea, Luis ^a,d  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cortistatin analogs; Electrophysiological techniques; Octapeptide analog; Octreotide; Somatostatin receptor

Indexed keywords

CORTISTATIN 14; LYSINE; NEUROPEPTIDE; PROLINE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HIPPOCAMPUS; LIGAND BINDING; LOCOMOTION; MALE; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT; SLEEP; SLOW BRAIN WAVE;

AMINO ACID SEQUENCE; ANIMALS; CEREBRAL VENTRICLES; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; NEUROPEPTIDES; OCTREOTIDE; OLIGOPEPTIDES; PROTEIN CONFORMATION; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; RECOMBINANT PROTEINS; SLEEP STAGES; SLEEP, REM; SOMATOSTATIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0033564534     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990615)56:6<611::AID-JNR7>3.0.CO;2-G     Document Type: Article

References (42)

1. Araujo DM, Lapchak PA, Collier B, Quirion R. 1990. Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus. J Neurochem 55:1546-1555.
2. Bakhit C, Swerdlow N. 1986. Behavioral changes following central injection of cysteamine in rats. Brain Res 365:159-163.
3. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless. 1982. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133-1140.
4. Beranek L, Obal F Jr, Taishi P, Bodosi B, Laczi F, Krueger JM. 1997. Changes in rat sleep after single and repeated injections of the long-acting somatostatin analog octreotide. Am J Physiol 273: R1484-1491.
5. Connor M, Ingram SL, Christie MJ. 1997. Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro. Br J Pharmacol 122:1567-1572.
6. Cronin A, Keifer JC, Baghdoyan HA, Lydic R. 1995. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist. Br J Anaesth 74:188-192.
7. Danguir J. 1986. Intracerebroventricular infusion of somatostatin selectively increases paradoxical sleep in rats. Brain Res 367:26-30.
8. de Lecea L, Criado JR, Prospero O, Gautvik KM, Schweitzer P, Danielson P, Dunlop CLM, Siggins GR, Henriksen SJ, Sutcliffe JG. 1996. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381:242-245.
9. de Lecea L, Ruiz-Lozano P, Danielson PE, Peele-Kirley J, Foye P, Frankel WN, Sutcliffe JG. 1997a. Cloning, mRNA expression and chromosomal mapping of human and mouse cortistatin. Genomics 42:499-506.
10. de Lecea L, del Rio JA, Criado JR, Alcantara S, Morales M, Henriksen SJ, Soriano E, Sutcliffe JG. 1997b. Cortistatin is expressed in a distinct subset of cortical interneurons. J Neurosci 17:5868-5880.
11. Fukusumi S, Kitada C, Takekawa S, Kizawa H, Sakamoto J, Miyamoto M, Hinuma S, Kitano K, Fujino M. 1997. Identification and characterization of a novel human cortistatin-like peptide. Biochem Biophys Res Commun 232:157-163.
12. Garzón M, Tejero S, Beneitez AM, de Andrés I. 1995. Opiate microinjections in the locus coeruleus area of the cat enhance slow wave sleep. Neuropeptides 29:229-239.
13. Hoyer D, Lubbert H, Bruns C. 1994. Molecular pharmacology of somatostatin receptors. Naunyn Schmiedbergs Arch Pharmacol 350:441-453.
14. Ishikawa Y, Shimatsu A, Murakami Y, Imura H. 1990. Barrel rotation in rats induced by SMS 201-995: suppression by ceruletide. Pharmacol Biochem Behav 37:523-526.
15. Kaupmann K, Bruns C, Raulf F, Weber HP, Mattes H, Lubbert H. 1995. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SRIFR2 somatostatin receptor. EMBO J 14:727-735.
16. Keri G, Erchegyi J, Horvath A, Mezo I, Idei M, Vantus T, Balogh A, Vadasz Z, Bokonyi G, Seprodi J, Teplan I, Csuka O, Tejeda M, Gaal D, Szegedi Z, Szende B, Roze C, Kalthoff H, Ullrich A. 1996. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. Proc Natl Acad Sci USA 93:12513-12518.
17. Liapakis G, Fitzpatrick D, Hoeger C, Rivier J, Vandlen R, Reisine T. 1996. Identification of ligand binding determinants in the somatostatin receptor subtypes 1 and 2. J Biol Chem 271:20331-20339.
18. Mancillas JR, Siggins GR, Bloom FE. 1986. Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex. Proc Natl Acad Sei USA 83:7518-7521.
19. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. 1998. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339.
20. Melacini G, Zhu Q, Goodman M. 1997. Multiconformational NMR analysis of sandostatin (octreotide): equilibrium between betasheet and partially helical structures. Biochemistry 36:1233-1241.
21. Nehring RB, Meyerhof W, Richter D. 1995. Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding. DNA Cell Biol 14:939-944.
22. Osapay G, Prokai L, Kirn HS, Medzihradszky KF, Coy DH, Liapakis G, Reisine T, Melacini G, Zhu Q, Wang SH, Mattern RH, Goodman M. 1997. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies. J Med Chem 40:2241-2251.
23. Ozenberger BA, Hadcock JR. 1995. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14. Mol Pharm 47:82-87.
24. Patel YC, Srikant CB. 1997. Somatostatin receptors. Trends Endocrinol Metab 8:398-405.
25. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. San Diego, CA: Academic Press.
26. Piwko C, Thoss VS, Probst A, Hoyer D. 1997. The elusive nature of cerebellar somatostatin receptors: studies in rat, monkey and human cerebellum. J Recept Signal Transduct Res 17:385-405.
27. Pohl E, Heine A, Sheldrick GM, Dauter Z, Wilson KS, Kallen J, Huber W, Pfaffli PJ. 1995. Acta Crystallogr D 51:48-59.
28. Prospero-Garcia O, Criado JR, Henriksen SJ. 1994. Pharmacology of ethanol and glutamate antagonists on rodent sleep: a comparative study. Pharmacol Biochem Behv 49:413-416.
29. Raynor K, Lucki I, Reisine T. 1993. Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats. J Pharmacol Exp Ther 265:67-73.
30. Reisine T, Bell GI. 1995. Molecular properties of somatostatin receptors. Neuroscience 67:777-790.
31. Rezek M, Havlicek V, Hughes KR, Friesen H. 1976. Cortical administration of somatostatin (SRIF): effect on sleep and motor behavior. Pharmacol Biochem Behav 5:73-77.
32. Schindler M, Humphrey PP, Emson PC. 1996. Somatostatin receptors in the central nervous system. Prog Neurobiol 50:9-47.
33. Schonbrunn A, Tashjian AH Jr. 1980. Modulation of somatostatin receptors by thyrotropin-releasing hormone in a clonal pituitary cell strain. J Biol Chem 255:190-198.
34. 3-octreotide labels human somatostatin sst2 and sst5 receptors. Eur J Pharmacol 348:311-320.
35. Siehler SS, Seuwen K, Hoyer D. 1998b. Cortistatin labels all five somatostatin receptors. Naunyn Schmiedbergs Arch Pharmacol 357:483-489.
36. Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, Koob GF. 1996. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273:1561-1564.
37. Steffensen S, Henriksen SJ. 1991. Effects of baclofen and bicuculline on inhibition in the fascia dentata and hippocampus regio superior. Brain Res 538:46-53.
38. Strnad J, Hadcock JR. 1995. Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SRIFR2. Biochem Biophys Res Commun 216:913-921.
39. Thoss VS, Perez J, Duc D, Hoyer D. 1995. Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 34:1673-1688.
40. Tran VT, Beal MF, Martin JB. 1985. Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science 228:492-495.
41. Vecsei L, Kiraly C, Bollok I, Nagy A, Varga J, Penke B, Telegdy G. 1984. Comparative studies with somatostatin and cysteamine in different behavioral tests on rats. Pharmacol Biochem Behav 21:833-837.
42. 1H 500 MHz. n.m.r. spectra and conformational analysis in aqueous solution. Int J Pept Protein Res 25:608-614.